Genomic Health, Inc. (GHDX ) Tops Q3 EPS by 6c

Genomic Health, Inc. (NASDAQ: GHDX ) reported Q3 EPS of $0.11, $0.06 better than the analyst estimate of $0.05. Revenue for the quarter came in at $58.6 million versus the consensus estimate of $59.85 million.

For earnings history and earnings-related data on Genomic Health, Inc. (GHDX ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Five Point Holdings, LLC (FPH) Reports Q1 EPS of $0.03
• Southern First Bancshares, Inc. (SFST) Misses Q1 EPS by 8c